Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance
Site Search
Showing 1 - 6 of 6 results
Press Release
|
Jan. 4, 2022
|
4 min read
Investment will support discovery research of a novel Gene CodingTM approach that could benefit all people with CF regardless of their mutation
Press Release
|
Jan. 5, 2022
|
5 min read
Dr. Steven Rowe will support mission to cure cystic fibrosis by leading the Foundation’s research strategy, focusing on genetic therapies
Press Release
|
Jan. 26, 2022
|
4 min read
Funding will support preclinical research and early-stage clinical trials
Press Release
|
Jan. 10, 2023
|
3 min read
The additional funding will support a Phase 2 clinical trial for an inhaled antisense oligonucleotide drug for people with cystic fibrosis who have the splicing mutation 3849+10Kb C-to-T.
Press Release
|
April 3, 2024
|
3 min read
Long-standing volunteers Kate O’Donnell and Amy Barry to co-chair major gift and planned giving campaign, continuing the legacy of beloved philanthropic leader Joe O’Donnell
Press Release
|
April 18, 2024
|
4 min read